Virtual Reality Therapy for Pain Management at the Emergency Department - Trial NCT06089642
Access comprehensive clinical trial information for NCT06089642 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud University Medical Center and is currently Not yet recruiting. The study focuses on Pain, Acute. Target enrollment is 124 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Radboud University Medical Center
Timeline & Enrollment
N/A
Dec 01, 2023
Apr 01, 2025
Primary Outcome
NRS-Pain score at rest
Summary
Rationale: Prescriptions of analgesics, especially opioids, have doubled in the Emergency
 department (ED) over the past decades in response to frequently reported undertreatment of
 pain in ED patients. Consequently, there is a shift towards a more restrained utilisation of
 opioids at the ED. However, there are still few (non-)pharmacological alternatives.
 
 Virtual Reality (VR) therapy is a relatively new and promising technique in non-pharmacologic
 pain reduction and anxiolysis and shows positive results on pain relief and pain.
 
 Objective: Primary objective is to investigate the effect of VR on patient-reported pain
 outcomes in the ED. Secondary objectives are to investigate the effect of VR on analgesics
 use, patient-reported outcomes, and process indicators and to identify barriers to
 implementation. Last, subanalyses will be performed to compare the effectiveness of two types
 of VR: VR based on distraction (VRD) and VR based on focussed attention (VRF).
 
 Study design: randomized controlled trial.
 
 Study population: Adults admitted to the ED with a NRS pain score of 4 (out of ten) or more
 and unacceptable pain.
 
 Intervention: There will be a control group receiving usual care and a intervention group
 that receives additional VR therapy.
 
 Main study parameters/endpoints: The main study outcome is the difference in patient-reported
 NRS pain score.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06089642
Device Trial

